Nader Najafian

Nader Najafian

Company: Alexion

Job title: Executive Director, Clinical Development Sciences


Panel Discussion: Challenges & Opportunities in Drug Development for Rare Kidney Diseases 3:30 pm

Incorporating clinical outcome assessments in trials Benefits of orphan drug designation and potential accelerated approval pathways in rare renal diseases Partnering with patient advocacy groups and registries in recruiting rare kidney disease patient populationsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.